Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FYSIOTERAPI NORDVEST ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   4.9% 3.6% 4.8% 6.3% 6.5% 7.6% 18.7% 18.3%   Credit score (0-100)   46 54 45 36 36 31 7 8   Credit rating   BBB BBB BBB BBB BBB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,741 4,955 4,881 6,215 6,344 4,916 0.0 0.0   EBITDA   910 746 399 344 881 156 0.0 0.0   EBIT   781 625 283 233 799 75.6 0.0 0.0   Pre-tax profit (PTP)   766.6 647.6 304.8 250.1 750.4 53.2 0.0 0.0   Net earnings   595.4 503.7 236.0 192.6 585.1 40.6 0.0 0.0   Pre-tax profit without non-rec. items   767 648 305 250 750 53.2 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   752 630 514 404 321 241 0.0 0.0   Shareholders equity total   1,160 1,114 900 592 877 418 292 292   Interest-bearing liabilities   981 915 1,176 1,506 1,617 2,037 0.0 0.0   Balance sheet total (assets)   2,980 2,765 3,019 3,012 3,420 3,302 292 292   Net Debt   974 901 1,165 1,505 1,596 2,021 -292 -292     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,741 4,955 4,881 6,215 6,344 4,916 0.0 0.0   Gross profit growth   8.1% 4.5% -1.5% 27.3% 2.1% -22.5% -100.0% 0.0%   Employees   9 10 9 13 13 10 0 0   Employee growth %   0.0% 11.1% -10.0% 44.4% 0.0% -23.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,980 2,765 3,019 3,012 3,420 3,302 292 292   Balance sheet change%   13.4% -7.2% 9.2% -0.2% 13.5% -3.5% -91.2% 0.0%   Added value   910.0 746.4 399.4 343.6 909.0 155.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -258 -242 -232 -221 -165 -161 -241 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   16.5% 12.6% 5.8% 3.8% 12.6% 1.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   28.8% 23.8% 11.8% 9.5% 25.4% 5.1% 0.0% 0.0%   ROI %   38.6% 31.6% 15.8% 13.2% 34.5% 6.7% 0.0% 0.0%   ROE %   60.3% 44.3% 23.4% 25.8% 79.6% 6.3% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   38.9% 40.3% 29.8% 19.7% 25.7% 12.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   107.1% 120.7% 291.7% 438.0% 181.1% 1,296.8% 0.0% 0.0%   Gearing %   84.6% 82.2% 130.7% 254.4% 184.3% 487.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.8% 3.7% 3.4% 2.8% 4.2% 6.4% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.1 1.2 1.1 1.0 1.1 0.9 0.0 0.0   Current Ratio   1.1 1.2 1.1 1.0 1.1 0.9 0.0 0.0   Cash and cash equivalent   6.5 14.2 11.1 1.4 21.5 16.2 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   146.5 252.5 172.1 -40.9 184.1 -209.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   101 75 44 26 70 16 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   101 75 44 26 68 16 0 0   EBIT / employee   87 63 31 18 61 8 0 0   Net earnings / employee   66 50 26 15 45 4 0 0